Checkmate Pharmaceuticals, Inc.

Ownership Transactions Reported by 15 Insiders

Industry
Biological Products, (No Diagnostic Substances)
Location
245 Main Street, 2 Nd Floor, Cambridge, MA

There are no Buy or Sell transactions made by insiders since 11/5/2023

Checkmate Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Holdings A/S Novo 10%+ Owner $22.6M Feb 23, 2022
venBio Global Strategic Fund II L.P. 10%+ Owner $22.5M May 13, 2022
Arthur M. Krieg Chief Scientific Officer $8.52M Jun 18, 2021
Keith T. Flaherty Director May 31, 2022
Peter Colabuono Director May 31, 2022
Oren Isacoff Director May 31, 2022
Kleem Chaudhary Chief Business Officer Aug 4, 2021
James Wooldridge Chief Medical Officer May 31, 2022
Robert Dolski Chief Financial Officer May 31, 2022
Joy Yan Director May 31, 2022
Alan Bash Chief Executive Officer, Director May 31, 2022
Michael Powell Director May 31, 2022
Barry Labinger President and CEO, Director Aug 4, 2021
Alan Fuhrman Director May 31, 2022
Jon Marc Wigginton Director May 31, 2022

Recent Insider Transactions by Companies or Individuals for Checkmate Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.